CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(11): E1020-E1025
DOI: 10.1055/a-2185-6192
Review

Cold snare resection for non-ampullary sporadic duodenal adenomas: systematic review and meta-analysis

Mihai Ciocirlan
1   "Agrippa Ionescu" Clinical Emergency Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
,
Diana Lavinia Opri
1   "Agrippa Ionescu" Clinical Emergency Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
,
Dana Maria Bilous
1   "Agrippa Ionescu" Clinical Emergency Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
,
Daniel-Corneliu Leucuta
2   Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania (Ringgold ID: RIN37576)
,
Elena Tianu
3   Pathology Department, "Agrippa Ionescu" Clinical Emergency Hospital, Bucharest, Romania
,
Catalina Vladut
1   "Agrippa Ionescu" Clinical Emergency Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
› Author Affiliations

Abstract

Background and study aims The role of cold snare polypectomy (CSP) in curative resection of non-ampullary sporadic duodenal adenomas (NASDA) is debated. We conducted a systematic review and meta-analysis to investigate the efficacy and safety of CSP for NASDA.

Patients and methods In this systematic review and meta-analysis, we identified published series of patients with CSP for NASDA by searching PubMed and Google Scholar, which resulted in six papers (205 lesions). The main outcome was the rate of local remission after repeated CSP, the secondary outcomes were rates of local remission at first control and rates for delayed bleeding and immediate perforations. We computed the weighted summary proportions under the fixed and random effects model.

Results The pooled proportion of local remission after repeated CSP was 88% (95% confidence interval [CI] 57%-100%). The pooled proportion of local remission at first control was 81% (95% CI 55%-98%), the pooled proportion of delayed bleeding was 1% (95% CI 0%-4%) and the pooled proportion of immediate perforation was 0% (95% CI 0%-2%).

Conclusions Our meta-analysis suggests that CSP should be considered as the first-line therapy for NASDA.

Supporting information



Publication History

Received: 26 April 2023

Accepted after revision: 27 September 2023

Accepted Manuscript online:
04 October 2023

Article published online:
09 November 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany